Johnson & Johnson
JNJ
#20
Rank
C$745.32 B
Marketcap
C$309.36
Share price
-0.02%
Change (1 day)
43.00%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

EPS for Johnson & Johnson (JNJ)

EPS in 2025 (TTM): C$14.74

According to Johnson & Johnson's latest financial reports the company's current EPS (TTM) is C$14.21. In 2024 the company made an earnings per share (EPS) of C$9.11 a decrease over its 2023 EPS that were of C$19.63.

EPS history for Johnson & Johnson from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$14.7461.78%
2024C$9.11-53.6%
2023C$19.63111.16%
2022C$9.30-13.84%
2021C$10.7941.81%
2020C$7.61-18.92%
2019C$9.3921.2%
2018C$7.741125.3%
2017C$0.63-92.23%
2016C$8.137.37%
2015C$7.57-4.16%
2014C$7.9018.1%
2013C$6.6924.88%
2012C$5.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
C$10.02-29.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$2.34-83.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$10.97-22.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
C$5.05-64.46%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
C$27.93 96.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$5.04-64.50%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
C$8.88-37.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
C$10.50-26.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.34-27.26%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$4.90-65.55%๐Ÿ‡ฌ๐Ÿ‡ง UK